Search results
1 company and 4 research reports found for "Renovo"
Company results
- Renovo
Renovo is a biopharmaceutical product company and is a leader in the discovery and development of dr...
Sector reports
No sector reports have been found.
Research results
Renovo
Juvista mortally scarred
Update | Pharmaceutical & Healthcare | 14/02/2011Renovo’s lead drug, Juvista, has failed its first Phase III trial in scar reductions. Shire will probably return the rights to the drug and further ...
Renovo
Ready for REVISE
Update | Pharmaceutical & Healthcare | 24/11/2010Renovo has successfully completed its first clinical trial for scar reduction with Juvista Paediatric and the best dosing of adult Juvista has been co...
Renovo
Inching forward
Update | Pharmaceutical & Healthcare | 10/09/2010Renovo has successfully completed a Phase I trial with Juvista in patients who had keloid scars excised. This has removed a potential hurdle for the a...
Renovo
In need of Juvista
Outlook | Pharmaceutical & Healthcare | 08/01/2010Renovo is well capitalised and has traded at or below its cash value for the last 18 months. While this would ostensibly suggest an investment opportu...
